Top stories in endocrinology: New oral diabetes drug demonstrates positive trial results; HbA1c, BP affect diabetic kidney disease progression HealioAmong the top stories in endocrinology last week were results from a phase 3 trial that found the experimental oral diabetes drug imeglimin achieved its primary ...